Resources

SSRI Testing Available in Umbilical Cord Tissue

04-Nov-2024

We are excited to announce the addition of SSRIs to our umbilical cord testing. Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that can be used to treat depression, anxiety, or other psychological disorders. Testing umbilical cord tissue identifies in-utero exposure during pregnancy. SSRIs will be an add on test available November 4th, 2024 and includes the following analytes: Venlafaxine o-desmethylvenlafaxine1 Norsertraline2 Duloxetine Fluoxetine Citalopram/Escitalopram3 n-desmethylcitalopram4 Paroxetine Fluvoxamine Trazodone Quetiapine 1. Perscribed drug and metabolite of venlafaxine 2. metabolite of sertraline 3. This assay does not distinguish between citalopram and escitalopram (Celexa/Lexapro) 4. metabolite of citalopram/escitalopram

Laboratory Improves Propofol Testing Following New Research Data

05-Jul-2013

New Cannabinoids for Meconium Specimens

10-Jun-2024

To provide you with outstanding drug testing service, we are transitioning meconium cannabinoid confirmation methods from GC-MS to LC-MS/MS beginning June 10, 2024.  The following cannabinoids will be updated/added:   Carboxy-delta-9-THC  Carboxy-delta-8-THC  Carboxy-cannabidiol (CBD)